Terms: = Bone cancer AND CALCB, Calcitonin AND Treatment
257 results:
1. Safety and Early Results for Off-Label Use of Intranasal calcitonin for treatment of Nondisplaced Acromial and Scapular Spine Stress Fractures After Reverse Total Shoulder Arthroplasty.
Mandalia K; Gulotta L; Ross G; Shah S
J Am Acad Orthop Surg Glob Res Rev; 2024 Apr; 8(4):. PubMed ID: 38546429
[TBL] [Abstract] [Full Text] [Related]
2. CALCRL induces resistance to daunorubicin in acute myeloid leukemia cells through upregulation of XRCC5/TYK2/JAK1 pathway.
Tang S; Li S; Shi X; Sheng L; Mu Q; Wang Y; Zhu H; Xu K; Zhou M; Xu Z; Wu A; Ouyang G
Anticancer Drugs; 2024 Feb; 35(2):163-176. PubMed ID: 37948318
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and Toxicity of calcitonin treatment in Children with Cherubism: A Single-Center Cohort Study.
Schreuder WH; Meijer EB; Cleven AHG; Edelenbos E; Klop C; Schreurs R; de Jong RT; van Maarle MC; Horsthuis RBG; de Lange J; van den Berg H
J Bone Miner Res; 2023 Dec; 38(12):1822-1833. PubMed ID: 37823782
[TBL] [Abstract] [Full Text] [Related]
4. treatment of hypercalcaemia of malignancy in adults.
Mc Donald D; Drake MT; Crowley RK
Clin Med (Lond); 2023 Sep; 23(5):503-507. PubMed ID: 37775175
[TBL] [Abstract] [Full Text] [Related]
5. Hypercalcaemia in a patient with tuberculous lymphadenitis.
Kulkarni M; Bhat A; Toolahally U; Kumar MU
BMJ Case Rep; 2023 Jul; 16(7):. PubMed ID: 37463774
[TBL] [Abstract] [Full Text] [Related]
6. cancer-related hypercalcemia and potential treatments.
Almuradova E; Cicin I
Front Endocrinol (Lausanne); 2023; 14():1039490. PubMed ID: 37033238
[TBL] [Abstract] [Full Text] [Related]
7. Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma.
Kesby N; Mechera R; Fuchs T; Papachristos A; Gild M; Tsang V; Clifton-Bligh R; Robinson B; Sywak M; Sidhu S; Chou A; Gill AJ; Glover A
J Clin Endocrinol Metab; 2023 Sep; 108(10):2626-2634. PubMed ID: 36964913
[TBL] [Abstract] [Full Text] [Related]
8. treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline.
El-Hajj Fuleihan G; Clines GA; Hu MI; Marcocci C; Murad MH; Piggott T; Van Poznak C; Wu JY; Drake MT
J Clin Endocrinol Metab; 2023 Feb; 108(3):507-528. PubMed ID: 36545746
[TBL] [Abstract] [Full Text] [Related]
9. A Systematic Review Supporting the Endocrine Society Clinical Practice Guideline on the treatment of Hypercalcemia of Malignancy in Adults.
Seisa MO; Nayfeh T; Hasan B; Firwana M; Saadi S; Mushannen A; Shah SH; Rajjoub NS; Farah MH; Prokop LJ; Wang Z; Fuleihan GE; Drake MT; Murad MH
J Clin Endocrinol Metab; 2023 Feb; 108(3):585-591. PubMed ID: 36545700
[TBL] [Abstract] [Full Text] [Related]
10. Prospective study on the clinical relevance of
Califano I; Pitoia F; Chirico R; De Salazar A; Bastianello MJ
Endocrine; 2022 Jun; 77(1):143-150. PubMed ID: 35489000
[TBL] [Abstract] [Full Text] [Related]
11. Atypical parathyroid adenoma: Severe manifestations in an adolescent girl.
Boro H; Alam S; Kubihal V; Khatiwada S; Kubihal S; Agarwal S; Khadgawat R
Pediatr Endocrinol Diabetes Metab; 2022; 28(1):91-100. PubMed ID: 35193332
[TBL] [Abstract] [Full Text] [Related]
12. Extension of Prophylactic Surgery in Medullary Thyroid Carcinoma. Differences Between Sporadic and Hereditary Tumours According to calcitonin Levels and Lymph Node Involvement.
Juez LD; Mercader E; Amunategui I; Febrero B; Rodríguez JM; Gómez-Ramírez J;
World J Surg; 2022 Apr; 46(4):820-828. PubMed ID: 35089388
[TBL] [Abstract] [Full Text] [Related]
13. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.
Roberts KE; Adsett IT; Rickett K; Conroy SM; Chatfield MD; Woodward NE
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013167. PubMed ID: 35005781
[TBL] [Abstract] [Full Text] [Related]
14. bone turnover markers can predict healing time in medication-related osteonecrosis of the jaw.
Schubert L; Russmueller G; Lagler H; Tobudic S; Heindel E; Kundi M; Steininger C
Support Care Cancer; 2021 Dec; 29(12):7895-7902. PubMed ID: 34189608
[TBL] [Abstract] [Full Text] [Related]
15. Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers.
Giannetta E; Sesti F; Modica R; Grossrubatscher EM; Guarnotta V; Ragni A; Zanata I; Colao A; Faggiano A
Front Endocrinol (Lausanne); 2021; 12():665698. PubMed ID: 34093441
[TBL] [Abstract] [Full Text] [Related]
16. Effect of cytotoxic chemotherapy on bone health among breast cancer patients. Does it require intervention?
Nisha Y; Dubashi B; Bobby Z; Sahoo JP; Kayal S
Support Care Cancer; 2021 Nov; 29(11):6957-6972. PubMed ID: 33954821
[TBL] [Abstract] [Full Text] [Related]
17. Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer.
Matrone A; Prete A; Nervo A; Ragni A; Agate L; Molinaro E; Giani C; Valerio L; Minaldi E; Piovesan A; Elisei R
J Endocrinol Invest; 2021 Oct; 44(10):2139-2151. PubMed ID: 33594641
[TBL] [Abstract] [Full Text] [Related]
18. Impact of 3D cell culture on bone regeneration potential of mesenchymal stromal cells.
Bicer M; Cottrell GS; Widera D
Stem Cell Res Ther; 2021 Jan; 12(1):31. PubMed ID: 33413646
[TBL] [Abstract] [Full Text] [Related]
19. Neuronal calcitonin gene-related peptide promotes prostate tumor growth in the bone microenvironment.
Zhu W; Sheng D; Shao Y; Zhang Q; Peng Y
Peptides; 2021 Jan; 135():170423. PubMed ID: 33086087
[TBL] [Abstract] [Full Text] [Related]
20. Aneurysmal bone cyst and osteoblastoma: an extremely rare combination in the pediatric spine.
Lazaro FA; Remondino RG; Piantoni L; Tello CA; Galaretto E; Francheri Wilson IA; Noel MA
Spine Deform; 2021 Mar; 9(2):615-620. PubMed ID: 33083998
[TBL] [Abstract] [Full Text] [Related]
[Next]
